Other Stories

Johnson & Johnson to start late-stage COVID-19 vaccine trial in September Updated: 2020-08-21 10:05:21 KST

Johnson & Johnson plans to begin what would be the largest, late-stage trial testing for a potential COVID-19 vaccine in September.
According to the U.S. pharmaceutical company Thursday, the phase three trial will enroll up to 60-thousand healthy people over 18 years old, across nearly 180 locations in the U.S., as well as other countries.
Participants will be randomly selected to receive a dose of the potential vaccine or a placebo, which will determine whether the vaccine is both safe and effective.
The company added that the participants will be followed by researchers for more than two years.
Johnson & Johnson expects possible vaccine batches for potential emergency use to be available in early 2021.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.